Where can I learn more about this study? You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.
- www.clinicaltrials.gov. Once you are on the website, type "NCT04435483" into the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D822FC00004" into the search box, and click "Find a Study".

Full Study Title: Phase I, Open-label, Single-dose, Sequential, Randomized, Crossover Study of Acalabrutinib Suspension Delivered via Nasogastric Tube in Healthy Subjects to Evaluate Relative Bioavailability and Proton-pump Inhibitor (Rabeprazole) Effect.

AstraZeneca Protocol Number: D822FC00004
National Clinical Trials Number: NCT04435483

AstraZeneca AB sponsored this study and has its headquarters at 151 85 Södertälje, Sweden.

Thank you!

Clinical study participants and their families belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org

Version 1.0 2021_03_29